CDC shortens Pfizer booster recommendation, adds recommendation for immunocompromised children
The Centers for Disease Control and Prevention signed off on two measures to increase access to Pfizer booster doses today.
The CDC recommended shortening the Pfizer booster eligibility interval from six months to five months. This would apply to anyone who received the Pfizer vaccine series initially. The recommendation has not changed for Johnson & Johnson or Moderna vaccine recipients at this time.
The CDC also recommends that moderately and severely immunocompromised 5-to-11 year olds get an additional primary dose of the vaccine 28 days after their second shot. The Pfizer COVID-19 vaccine is still the only vaccine recommended and authorized for children ages 5-to-11.
This recommendation is consistent with the CDC’s prior recommendation for adults.
COPYRIGHT 2022 BY NEWS 8 NOW/NEWS 8000. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.